CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $58.16M, above the global median of $18.92M
- FinancialsAltman Z-Score 3.17: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.69%Above 5Y avg (3.05%)
Annual Rate
TWD 1.75Paid annual
Payout Ratio
179.6%High
Payback Period
17.9 yr
Last Ex-Dividend
Aug 17, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
23.02BTWD723.38M · vs all stocks (USD)
Trailing P/E
76.75xRevenue (TTM)
1.66BTWD52.07M · vs all stocks (USD)
Profit Margin
61.51%Beta
0.2660xvs all stocks
52-Week Change
-13.47%vs all stocks
Market Capitalization
23.02BTWD723.38M · vs all stocks (USD)
Enterprise Value
24.94BTWD783.76M · vs all stocks (USD)
Trailing P/E
76.75xPEG Ratio
0.0607xPrice to Sales (TTM)
13.87xPrice to Book (MRQ)
1.42xEnterprise to Revenue
15.05xEnterprise to EBITDA
112.04xGross Margin
43.65%Profit Margin
61.51%Return on Assets (TTM)
0.15%Return on Equity (TTM)
6.00%Revenue (TTM)
1.66BTWD52.07M · vs all stocks (USD)
Revenue per Share (TTM)
2.10TWDUpdated Sep 21, 2026Quarterly Revenue Growth
14.10%Gross Profit (TTM)
716.93MTWD22.53M · vs all stocks (USD)
EBITDA (TTM)
222.57MTWD7.00M · vs all stocks (USD)
Net Income (TTM)
1.02BTWD32.03M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
14.09%Operating Cash Flow (TTM)
283.16MTWD8.90M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.85BTWD58.16M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.75TWDUpdated Sep 21, 2026Trailing Annual Dividend Yield
5.69%vs all stocks
5-Year Average Dividend Yield
3.05%vs all stocks
Payout Ratio
179.58%Minority Interest (Equity)
6.00KTWDFY2025 · Dec 31, 2025Revenue
1.52BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
894.93MTWDFY2025 · Dec 31, 2025Gross Profit
621.26MTWDFY2025 · Dec 31, 2025Operating Income
-362.08MTWD-11.38M · vs all stocks (USD)
Pre-tax Income
11.57BTWDFY2025 · Dec 31, 2025Income Tax Expense
2.25BTWDFY2025 · Dec 31, 2025Net Income
9.32BTWDFY2025 · Dec 31, 2025EBIT
11.77BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-265.57MTWDFY2025 · Dec 31, 2025Research & Development
84.78MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
449.67MTWDFY2025 · Dec 31, 2025Other Operating Expenses
448.88MTWDFY2025 · Dec 31, 2025Non-operating Interest Income
31.66MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
204.36MTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00TWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
11.68BTWDFY2025 · Dec 31, 2025Free Cash Flow
11.48BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
237.56MTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
11.57BTWDFY2025 · Dec 31, 2025Stock-based Compensation
7.15MTWDFY2025 · Dec 31, 2025Other Non-cash Items
175.42MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-31.14MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-39.50MTWDFY2025 · Dec 31, 2025Capital Expenditures
-205.50MTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.71MTWDFY2025 · Dec 31, 2025Net Acquisitions
328.80MTWDFY2025 · Dec 31, 2025Purchase of Investments
-75.37MTWDFY2025 · Dec 31, 2025Sale of Investments
1.45BTWDFY2025 · Dec 31, 2025Other Investing Activity
-2.65MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
1.50BTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
250.90MTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-2.20BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-212.00MTWDFY2025 · Dec 31, 2025Common Stock Repurchase
-383.08MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-540.27MTWDFY2025 · Dec 31, 2025Other Financing Charges
-2.13MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-3.09BTWDFY2025 · Dec 31, 2025Shares Outstanding
791.02MSharesUpdated Sep 21, 2026Float Shares
591.07MSharesUpdated Sep 21, 2026% Held by Insiders
25.48%vs all stocks
% Held by Institutions
7.52%vs all stocks
Total Cash (MRQ)
3.61BTWD113.34M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.56TWDUpdated Sep 21, 2026Total Debt (MRQ)
4.10BTWD128.89M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2391xCurrent Ratio (MRQ)
1.85xBook Value per Share (MRQ)
21.69TWDUpdated Sep 21, 2026Total Assets
34.63BTWD1.09B · vs all stocks (USD)
Total Current Assets
1.59BTWDFY2025 · Dec 31, 2025Total Liabilities
8.14BTWDFY2025 · Dec 31, 2025Total Non-current Assets
33.04BTWDFY2025 · Dec 31, 2025Total Non-current Liabilities
4.63BTWDFY2025 · Dec 31, 2025Total Current Liabilities
3.51BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents
237.56MTWDFY2025 · Dec 31, 2025Other Short-term Investments
736.64MTWDFY2025 · Dec 31, 2025Accounts Receivable
214.17MTWDFY2025 · Dec 31, 2025Inventory
353.48MTWDFY2025 · Dec 31, 2025Accounts Payable
119.32MTWDFY2025 · Dec 31, 2025Short-term Debt
2.93BTWDFY2025 · Dec 31, 2025Other Current Liabilities
20.43MTWDFY2025 · Dec 31, 2025Long-term Debt
1.77BTWDFY2025 · Dec 31, 2025Other Non-current Liabilities
906.00KTWDFY2025 · Dec 31, 2025Common Stock (Book)
7.61BTWDFY2025 · Dec 31, 2025Retained Earnings
9.33BTWDFY2025 · Dec 31, 2025Total Shareholders' Equity
26.49BTWD832.45M · vs all stocks (USD)
Treasury Stock
592.73MTWDFY2025 · Dec 31, 202552-Week Low
29.35TWDUpdated Sep 21, 202652-Week High
48.96TWDUpdated Sep 21, 202652-Week Change
-13.47%vs all stocks
Beta
0.2660xvs all stocks
50-Day MA
33.62TWDUpdated Sep 21, 2026200-Day MA
37.06TWDUpdated Sep 21, 2026Avg 10-Day Volume
1.55MSharesUpdated Sep 21, 2026Avg 30-Day Volume
2.26MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.4000TWDUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 32,026,716.219Operating Cash Flow (USD, TTM): 8,899,341.102
Financial Health
Altman Z-Score 3.17: safe zoneNotable
Altman Z-Score: 3.17
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $58.16M, above the global median of $18.92MNotable
Levered free cash flow (USD): 58,160,855.995Global Median: 18,920,810.7
Companies that share the same coordination system — how they create, deliver, or capture value.
Wave Life Sciences Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beijing Beilu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhongzhu Healthcare Holding Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Sanyou Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Knight Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Yabao Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cytek Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen Lifotronic Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Konruns Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Genomma Lab Internacional S.A.B. de C.V.
Tier 1ProductionApproval-Gated PipelineRuleFlow